592 related articles for article (PubMed ID: 24513968)
1. Dendritic cells and cancer immunotherapy.
Radford KJ; Tullett KM; Lahoud MH
Curr Opin Immunol; 2014 Apr; 27():26-32. PubMed ID: 24513968
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-based immunotherapy.
Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
[TBL] [Abstract][Full Text] [Related]
3. Harnessing dendritic cells in cancer.
Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
[TBL] [Abstract][Full Text] [Related]
4. NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge.
Bouwer AL; Saunderson SC; Caldwell FJ; Damani TT; Pelham SJ; Dunn AC; Jack RW; Stoitzner P; McLellan AD
J Immunol; 2014 Mar; 192(5):2514-21. PubMed ID: 24477907
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-based nanovaccines for cancer immunotherapy.
Paulis LE; Mandal S; Kreutz M; Figdor CG
Curr Opin Immunol; 2013 Jun; 25(3):389-95. PubMed ID: 23571027
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-based vaccines in breast and gynaecologic cancer.
Hernando JJ; Park TW; Kuhn WC
Anticancer Res; 2003; 23(5b):4293-303. PubMed ID: 14666641
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
9. Presentation of tumour antigens by dendritic cells and challenges faced.
Robson NC; Hoves S; Maraskovsky E; Schnurr M
Curr Opin Immunol; 2010 Feb; 22(1):137-44. PubMed ID: 20116984
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells for specific cancer immunotherapy.
Meidenbauer N; Andreesen R; Mackensen A
Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
[TBL] [Abstract][Full Text] [Related]
11. The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.
Salem ML
Methods Mol Biol; 2014; 1139():479-503. PubMed ID: 24619701
[TBL] [Abstract][Full Text] [Related]
12. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
13. The use of dendritic cells in cancer immunotherapy.
Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
[TBL] [Abstract][Full Text] [Related]
14. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ
Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240
[TBL] [Abstract][Full Text] [Related]
15. Induction of Bcl-xL-specific cytotoxic T lymphocytes in mice.
Larsen HL; Andersen MH; Wandall HH; Madsen CB; Christensen RE; Petersen TR; Pedersen AE
Scand J Immunol; 2014 Aug; 80(2):111-20. PubMed ID: 24846184
[TBL] [Abstract][Full Text] [Related]
16. Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.
Huang FP; Chen YX; To CK
Eur J Immunol; 2011 Jan; 41(1):18-25. PubMed ID: 21182072
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ
Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625
[TBL] [Abstract][Full Text] [Related]
18. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
Rossowska J; Pajtasz-Piasecka E
Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
[TBL] [Abstract][Full Text] [Related]
19. mRNA-based dendritic cell vaccines.
Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
[TBL] [Abstract][Full Text] [Related]
20. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]